International Society for Cell & Gene Therapy Presentations Illustrate Evox Therapeutics’ Proprietary Exosome Engineering Platform with New Data on Exosome Targeting and In Vivo Distribution
May 09, 2022 07:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, May 09, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announced two oral presentations at the...
Evox Therapeutics Appoints Peter Jones as Vice President of CMC
April 14, 2022 07:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, April 14, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announces the appointment of Peter Jones as Vice...
Evox Therapeutics Expands Its Exosome Patent Portfolio
November 02, 2021 07:00 ET
|
EVOX THERAPEUTICS LIMITED
Newly issued patent covers proprietary approach for loading nucleic acids into exosomes OXFORD, United Kingdom, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a...